109 related articles for article (PubMed ID: 6172193)
1. Cytotoxicity of a new uridine analog, 4-hydroxy-1-(beta-D-ribofuranosyl)-pyridazine-6-one, and its interaction with uridine kinase.
Bloomer LC; Wotring LL; Townsend LB
Cancer Res; 1982 Jan; 42(1):100-6. PubMed ID: 6172193
[TBL] [Abstract][Full Text] [Related]
2. Effects of D-glucosamine and 6-azauridine on nucleotide contents, 5-fluorouridine uptake, and cytotoxicity in TA3 mammary tumor cells.
Holstege A; Keppler D
J Natl Cancer Inst; 1986 Mar; 76(3):485-92. PubMed ID: 2419623
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of uridine kinase and the salvage of uridine by modified pyrimidine nucleosides.
Moyer JD; Karle JM; Malinowski N; Marquez VE; Salam MA; Malspeis L; Cysyk RL
Mol Pharmacol; 1985 Nov; 28(5):454-60. PubMed ID: 2997596
[TBL] [Abstract][Full Text] [Related]
4. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
Katahira R; Ashihara H
Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448
[TBL] [Abstract][Full Text] [Related]
5. Properties of uridine-cytidine kinase derived from L1210 leukemia cells.
Ahmed NK; Baker DR
Cancer Res; 1980 Oct; 40(10):3559-63. PubMed ID: 6254634
[TBL] [Abstract][Full Text] [Related]
6. Identification of 6-azauridine triphosphate in L1210 cells and its possible relevance to cytotoxicity.
Wotring LL; Townsend LB
Cancer Res; 1989 Jan; 49(2):289-94. PubMed ID: 2463073
[TBL] [Abstract][Full Text] [Related]
7. [Isolation and properties or uridine kinase from Zajdela hepatoma cells].
Dubinina IG; Shkurko VG; Vornovitskaia GI
Biokhimiia; 1981 Oct; 46(10):1905-16. PubMed ID: 6272884
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.
Brockman RW; Cheng YC; Schabel FM; Montgomery JA
Cancer Res; 1980 Oct; 40(10):3610-5. PubMed ID: 6254636
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of pyridazine analogues of the naturally occurring nucleosides cytidine, uridine, deoxycytidine, and deoxyuridine.
Katz DJ; Wise DS; Townsend LB
J Med Chem; 1982 Jul; 25(7):813-21. PubMed ID: 7108897
[TBL] [Abstract][Full Text] [Related]
10. Study of the cytotoxicity and metabolism of 4-amino-3-carboxamido-1-(beta-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine using inhibitors of adenosine kinase and adenosine deaminase.
Wotring LL; Townsend LB
Cancer Res; 1979 Aug; 39(8):3018-23. PubMed ID: 222442
[TBL] [Abstract][Full Text] [Related]
11. Conformation of pyridazine nucleosides: the molecular structure of 4-hydroxy-1-(beta-D-ribofuranosyl)pyridazin-6-one (3-deaza-6-azauridine).
Graves BJ; Hodgson DJ; Katz DJ; Wise DS; Townsend LB
Biochim Biophys Acta; 1978 Aug; 520(1):229-32. PubMed ID: 698230
[TBL] [Abstract][Full Text] [Related]
12. Effect of uridine on response of 5-azacytidine-resistant human leukemic cells to inhibitors of de novo pyrimidine synthesis.
Grant S; Bhalla K; Gleyzer M
Cancer Res; 1984 Dec; 44(12 Pt 1):5505-10. PubMed ID: 6208998
[TBL] [Abstract][Full Text] [Related]
13. Characterization of pyrimidine nucleoside monophosphokinase in normal and malignant tissues.
Arima T; Akiyoshi H; Fujii S
Cancer Res; 1977 Jun; 37(6):1593-7. PubMed ID: 192455
[TBL] [Abstract][Full Text] [Related]
14. Homogeneous uridine kinase from Ehrlich ascites tumor: substrate specificity and inhibition by bisubstrate analogs.
Cheng N; Payne RC; Kemp WE; Traut TW
Mol Pharmacol; 1986 Aug; 30(2):159-63. PubMed ID: 3016499
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies of the cytostatic action and metabolism of 5-azacytidine and 5,6-dihydro-5-azacytidine.
Voytek P; Beisler JA; Abbasi MM; Wolpert-DeFilippes MK
Cancer Res; 1977 Jul; 37(7 Pt 1):1956-61. PubMed ID: 67884
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Newcastle disease virus replication by 6-azauridine. I. Inefficacy of purified uridine kinase, effect of adenosine-5'-triphosphate.
Rada B; Dragún M
Acta Virol; 1976 Apr; 20(2):97-101. PubMed ID: 5878
[TBL] [Abstract][Full Text] [Related]
17. Nucleosides and nucleotides. 175. Structural requirements of the sugar moiety for the antitumor activities of new nucleoside antimetabolites, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and -uracil1.
Hattori H; Nozawa E; Iino T; Yoshimura Y; Shuto S; Shimamoto Y; Nomura M; Fukushima M; Tanaka M; Sasaki T; Matsuda A
J Med Chem; 1998 Jul; 41(15):2892-902. PubMed ID: 9667977
[TBL] [Abstract][Full Text] [Related]
18. [Effect of chemotherapy on the nucleoside phosphate kinase activity in experimental tumors].
Tret'iakov AV; Filov VA
Vopr Onkol; 1986; 32(11):95-8. PubMed ID: 3024413
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of 5-phosphoribosyl-1-pyrophosphate synthetase by the monophosphate metabolite of 4-amino-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine: a novel mechanism for antitumor activity.
Fry DW; Boritzki TJ; Jackson RC; Cook PD; Leopold WR
Mol Pharmacol; 1993 Aug; 44(2):479-85. PubMed ID: 7689145
[TBL] [Abstract][Full Text] [Related]
20. Enzymes relevant to cancer chemotherapy II. Heterogeneity of rat kidney uridine kinase following chromatography on Sepharose 6B coupled to N4-(5-amino-Pentyl)-cytidine.
Veselý J; Smrt J
Neoplasma; 1977; 24(5):461-7. PubMed ID: 200858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
